PatientsVille.com Logo

DISORIENTATION and Mirtazapine

PatientsVille

DISORIENTATION Symptoms and Causes

Have you ever felt dizzy, lightheaded, or as if the room is spinning around you? If the feeling happens often, it could be a sign of a balance problem. Balance problems can make you feel unsteady. You may also have blurred vision, confusion, and Disorientation. They are one cause of falls and fall-related injuries, such as a hip fracture.

Some balance problems are due to problems in the inner ear. Others may involve another part of the body, such as the brain or the heart. Aging, infections, head injury, certain medicines, or problems with blood circulation may also cause balance problems.

It is important to see your doctor about balance problems. They can be a sign of other health problems, such as an ear infection or a stroke. Your doctor may send you to a specialist for a diagnosis. You may need a hearing test, blood tests, or imaging studies of your head and brain. Other possible tests look at your eye movements, and how your body responds to movement.

In some cases, treating the illness that is causing the disorder will help with the balance problem. Exercises, a change in diet, and some medicines also can help.

NIH: National Institute on Deafness and Other Communication Disorders

Check out the latest treatments for DISORIENTATION

DISORIENTATION treatment research studies

Mirtazapine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Mirtazapine Side Effects

Completed Suicide (237)
Confusional State (206)
Hyponatraemia (180)
Depression (160)
Overdose (148)
Anxiety (147)
Fall (136)
Dizziness (130)
Agitation (130)
Condition Aggravated (123)
Somnolence (117)
Insomnia (113)
Headache (110)
Serotonin Syndrome (109)
Suicidal Ideation (107)
Fatigue (105)
Loss Of Consciousness (104)
Convulsion (103)
Aggression (103)
Suicide Attempt (100)
Nausea (96)
Oedema Peripheral (93)
Dyspnoea (92)
Weight Increased (90)
Tachycardia (90)
Tremor (84)
Malaise (82)
Vomiting (75)
Restless Legs Syndrome (75)
Myalgia (73)
Alanine Aminotransferase Increased (72)
Cardiac Arrest (71)
Inappropriate Antidiuretic Hormone Secretion (71)
Feeling Abnormal (70)
Toxicity To Various Agents (69)
Asthenia (69)
Diarrhoea (67)
Syncope (62)
Hyperhidrosis (61)
Neuroleptic Malignant Syndrome (61)
Pain In Extremity (61)
Electrocardiogram Qt Prolonged (60)
Pyrexia (59)
Aspartate Aminotransferase Increased (58)
Pulmonary Embolism (57)
Arthralgia (56)
Hypotension (56)
Irritability (56)
Pain (55)
Gait Disturbance (54)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

i have been on citalopram and amatripolineand fluxaitne i have been on 15mg of mirtazapine and tryed 30mg the doc has put me on 45mg and i asked if these tablets dont work what is next hes said shrink as i have tryed all the ones he said but i have

My symptoms were tired, weak, unable to sleep. Was prescribed half of a 15 MG Mirtazapine nightly to help me sleep. Has this drug been successful used as a sleeping aid?

The above comment is too stupid, I actually LOLed at you Pete... lol you gave it 2 days and your complaining about the side-effects? and on 15 mgs? LMAO!!! It takes couple weeks at least to cope with the side-effects; just like m

48 year old male, I have suffered depression all my life. Have used SSRI's for the last ten years with good but mixed results. Last year lost my job due to an episode where I ended up throwing my monitor across the office and have not been able to wo

After a nasty experience with citalapram i was advised by my doc to try mirtazapine and it has suitedme very well. only side effect i canreport is an appetite increase. However as i don't carry much weight that isnt a problem.&

Back pain

Been on 90mg mirtazapine for 6 years twice the recomended dose is this considered safe

Body covered in hives

Does mirtazapine have muscles side effects?

Hi, I have been on mittazapine for 10 days, sleepy , tierd all the time and slugish in response to conversation just horrid feel gastly , head ace, The worst went to bed 11pm took the 15mg pill, went to the loo at 3am and collapse

1+ years on this carvedilol 12.5 once a day then increased to 2x per day. Asthma symptoms, tightness in the chest, confusion, dizziness, some heart palpitation, ringing in the ears, disorientation (the worst). 57 yr old male, reasonable health for a

Anxiety,neck pain, felling tired,extreme pressure on head,disorientation,my throat fells like someone is choking me,fast hearth beat .

Dizziness, confusion, slurred speach.disorientation

Due to my nervous system disorer, doctor gave me two nerve medicines. I couldn't take the first one which caused me total weakness and disorientation. I take the 2nd one, Sertaline, half a tablet daily. I have one kidney only, so I take everything in

My mom took 9 tablets of the acetazolamide until the doctor advised her to stop taking it due to disorientation to time and place. Will the side effects disappear after stopping the medicine? Will she get back to her usual oriented state? Pls. repl

My son experienced nightmares, several night wakenings, disorientation, restlessness, night sweats and a few days after stopping the medication had shortness of breath after exercising (with no previous asthmatic experiences)

Never felt so ill in my life dizziness feeling sick could not eat for a day. disorientation. only took two tablets, but it did seem to block pain,

Sensitivetofluorescentlights,dizziness,loss of appetite,necrosis, INR all over the range (with testing 3 times a week, had to cut pills with a razor to get required dosage),<b>disorientation</b>,let

Some pain relief. Mild disorientation and vomiting

Waves of dizzines and disorientation. Horrible feeling! I am asking the doctor to give me an alternative

DISORIENTATION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Validation of a French Version of the Confusion Assessment Method (CAM)
Conditions: Confusion;   Delirium
Interventions: Other: Psychiatric evaluation;   Other: Geriatric evaluation
Outcome Measures: CAM French Version: diagnostic properties;   Reliability and quality of the french version of the CAM;   Feasibility of scoring with the French version of the Delirium Index;   Diagnostic properties of alternative algorithms constructed from items of CAM (French version)
2 Unknown  Use of a Vibrotactile Sensory Prosthesis in Patients With Postural Imbalance and Spatial Disorientation
Conditions: Vestibular Diseases;   Peripheral Neuropathies;   Proprioceptive Disorders;   Hemispatial Neglect
Intervention: Device: Vibrotactile feedback
Outcome Measure: Mean time reaction to the perturbation with the feedback
3 Recruiting Confusion in the Elderly After Colon Surgery
Conditions: Confusion;   Inflammation;   Acute Phase Reaction;   Surgery;   Delirium
Intervention:
Outcome Measures: Confusion;   degree of inflammation;   presence of electrolyte imbalance;   pituitary-thyroid axis disruption;   liver function tests;   nutritional status
4 Not yet recruiting Inadequate Emergence After Laparoscopic Surgery in Trendelemburg Position
Conditions: Delayed Emergence From Anesthesia;   Delirium, Cause Unknown;   Confusion;   Disorientation on Emergence
Intervention:
Outcome Measure: Inadequate emergence after anaesthesia
5 Recruiting Instruments for Delirium Assessment Regarding to Analgesia Sedation and Ventilator Status
Condition: Delirium
Intervention:
Outcome Measures: Sensitivity of the delirium screening/diagnosing tool "Confusion Assessment Method for the ICU (CAM-ICU)" regarding sedation and ventilator status.;   Sensitivity of the delirium-screening tool "Intensive-Care Delirium Screening Checklist(ICDSC)" regarding sedation and ventilator status.;   Sensitivity of the delirium screening tool "Nursing Delirium Screening Scale (Nu-DESC)" regarding sedation and ventilator status.;   Specificity of the "Confusion Assessment Method for the ICU (CAM-ICU)", the "Intensive Care Delirium Screening Checklist (ICDSC)" and the "Nursing Delirium Screening Scale" regarding sedation and ventilator status.;   Calculation and Analysis of the positive predictive values of the assessed delirium-screening scales.;   Incidence of delirium;   Incidence of Subsyndromale Delirium (SSD);   Analgesia;   Ventilator status;   Administered neuroleptics, cumulative;   Administered analgesics, cumulative;   Administered sedatives, cumulative;   Severity of illness;   Antibiotics/infections;   ICU length of stay;   Duration of mechanical ventilation;   Discharge mode;   28-day mortality;   Specificity of the "Confusion Assessment Method for the ICU (CAM-ICU)", the "Intensive Care Delirium Screening Checklist (ICDSC)" and the "Nursing Delirium Screening Scale" regarding analgesia.;   Sensitivity of the "Confusion Assessment Method for the ICU (CAM-ICU)", the "Intensive Care Delirium Screening Checklist (ICDSC)" and the "Nursing Delirium Screening Scale" regarding analgesia.
6 Unknown  Prevalence of Delirium in Patients Undergoing Cardiac Surgery
Condition: Heart Disease
Intervention:
Outcome Measure:
7 Recruiting Hip Fracture Surgery in Elderly Patients
Condition: Delirium
Interventions: Drug: Xenon;   Drug: Sevoflurane
Outcome Measures: Post Operative Delirium diagnosed with the Confusion Assessment Method within four days post-surgery;   Post Operative Delirium diagnosed with the Confusion Assessment Method from day 5 post surgery to discharge from hospital;   Sequential Organ Failure Assessment from day 1 to day 4 post-surgery;   Recovery Parameters;   economic parameters;   Safety Parameters
8 Unknown  Automated Visual Monitoring for Improving Patient Safety (VIPSafe)
Condition: Postoperative Confusion
Intervention:
Outcome Measure:
9 Not yet recruiting The Effect of Clonidine-enhanced Sedation on Delirium in Ventilated Critically Ill Patients
Condition: Delirium
Interventions: Drug: Clonidine;   Drug: SodiumChloride
Outcome Measures: CAM-ICU (Confusion Assessment Method for the Intesive Care Unit);   Signs of agitation;   Opiate use;   Sedative use;   Anti-psychotic use;   Ventilation free days;   Sedation free days
10 Unknown  Influence of Light Therapy on Confusion in Patients at the Intensive Care Unit
Conditions: Delirium;   Intensive Care Unit Syndrome
Intervention:
Outcome Measures: Duration of delirium, defined in days;   Incidence of delirium in the patient group receiving bright light therapy and in the group receiving environmental light;   CAM-scores of the ICU nurses;   Dosage of haloperidol use in delirious patients receiving bright light therapy and those receiving environmental light;   Duration of haldol use in delirious patients receiving bright light therapy and those receiving environmental light;   Mortality of delirious patients in the ICU and in the hospital, comparing those who receive bright light therapy with those who receive environmental light;   Duration of mechanical ventilation in delirious patients receiving bright light therapy and those receiving environmental light;   Duration of admission of delirious patients in the ICU and in the hospital, comparing those who receive bright light therapy with those who receive environmental light;   Duration of admission in the ICU and in the hospital, comparing those who receive bright light therapy with those who receive environmental light
11 Recruiting Early Nurse Detection and Management of Delirium
Condition: Delirium Superimposed on Dementia
Intervention: Behavioral: END-DSD
Outcome Measures: Severity of Delirium;   Inappropriate CNS-Active Medication Use;   Nurse Detection of Delirium;   Delirium Duration
12 Unknown  Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol
Condition: Subsyndromal Delirium
Interventions: Drug: Haloperidol decanoate;   Drug: Placebo
Outcome Measures: Conversion from subsyndromal delirium to delirium during the period of study drug administration (up to 10 days).;   The number of hours spent agitated (SAS >/=5) as percent of time study drug administered (up to 10 days).;   Duration of mechanical ventilation.;   Clinically significant QTc interval prolongation (≥ 500 msec or an increase of more than 60msec above baseline);   Extrapyramidal effects (as evidenced by a positive Simpson-Angus Scale Score);   The number of hours spent excessively sedated (SAS ≤ 2) as a percent of time study drug administered (up to 10 days).;   Cognition, incidence of anxiety, incidence of depressive symptoms, quality of life (ie., functional status and emotional well being)and sleep quality.
13 Recruiting Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes.
Conditions: Hypo-unawareness;   Type 1 Diabetes.
Intervention: Dietary Supplement: Medium chain triglycerides
Outcome Measures: Cognitive function tests;   Brain activity
14 Recruiting Decreasing the Incidence of Delirium After Cardiac Surgery
Conditions: Cardiac Surgical Patients;   Delirium
Interventions: Drug: Benzodiazepine;   Drug: Fentanyl;   Drug: propofol
Outcome Measure: Delirium
15 Not yet recruiting Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium
Condition: Postoperative Confusion
Interventions: Drug: Haloperidol;   Drug: Placebo
Outcome Measures: Feasibility of conducting a trial utilizing low dose Haloperidol use in patients post cardiac surgery;   Safety monitoring of low dose Haloperidol use in patients post cardiac surgery;   The incidence of delirium;   Delirium severity;   Total length of stay (LOS), with breakdown for intensive care unit (ICU) days and ward days;   Duration of delirium
16 Not yet recruiting Effects of Dexmedetomidine on Postoperative Cognitive Dysfunction During One-lung Ventilation in Elder Patients
Condition: Postoperative Confusion
Interventions: Drug: Induction of anesthesia,midazolam ,fentanyl,etomidate and rocuronium;   Drug: Dexmedetomidine;   Drug: Normal saline;   Drug: Maintenance of anesthesia , propofol, remifentanil,vecuronium
Outcome Measures: The change in learning;   The change in memory;   Cognitive function;   Postoperative anxiety;   Variation degree of Heart rate;   Airway pressure;   Variation degree of blood gas analysis;   Bleeding volume;   Total volume of fluid;   Duration of one lung ventilation;   Duration of two-lung ventilations;   The total dose of anaesthetic drugs;   The total dose of analgesic drugs;   Variation degree of blood pressure;   Oxygen saturation;   End-tidal carbon dioxide
17 Recruiting Effect of Music on Attention and Prospective Memory in Hepatic Encephalopathy
Conditions: Cirrhosis;   Hepatic Encephalopathy
Intervention:
Outcome Measures: Lure Response Inhibition on Inhibitory Control Test;   Target Responses on Inhibitory Control Test
18 Recruiting Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients
Conditions: Non-metastatic Patients With Breast Cancer;   Non-metastatic Patients With Colon Cancer;   Non-metastatic Patients With Rectal Cancer;   Patients Undergoing Adjuvant Chemotherapy
Intervention: Other: Clinical and psychosocial phone calls
Outcome Measures: emotional state (anxiety, depression, confusion, angry, fatigue, force and interpersonal relation);   Evolution of emotional states scores;   toxicities;   quality of life;   anxiety;   caregiver mood states;   patient satisfaction;   relationship between psychosocial criteria and anxiety
19 Recruiting Efficacy of Quetiapine for Pediatric Delirium
Condition: Delirium
Interventions: Drug: quetiapine;   Other: Placebo
Outcome Measures: Time to first resolution of delirium;   Total ICU days with delirium
20 Recruiting Efficacy and Safety of Risperidone and Trazodone Monotherapy and Combination Therapy in Critically Ill Patients With Delirium
Conditions: Delirium;   Agitation
Interventions: Drug: Risperidone;   Drug: Trazodone;   Drug: Placebo
Outcome Measures: The number of days patients are without delirium during the study period (delirium-free days);   Daily prevalence of delirium as indicated by a positive Confusion Assessment Method in the ICU (CAM-ICU);   Resolution of delirium as indicated by a negative Confusion Assessment Method in the ICU (CAM-ICU) for more than 24 hours;   The number of patients who require rescue medications, the type of rescue medications utilized, and the amount of rescue medications per day;   The number of patients who receive sedative agents, amount of midazolam equivalents per day, and the number of days in which patients receive a sedative agent;   The number of patients who receive pain medications, amount of fentanyl equivalents per day, and the number of days in which patients receive a pain medication;   The number of hours spent agitated (RASS score between +4 and +2) as a percent of the time that the study drug was administered;   The number of hours spent excessively sedated or in a coma state (RASS score between -4 to -5) as a percent of the time that the study drug was administered;   The duration of mechanical ventilation from initial intubation to extubation as long as the patient remained extubated for more than 48 hours.;   The number of days that the patients were alive and breathing without assistance during the study period (ventilator-free days);   The number of episodes and number of patients who experience clinically significant QTc prolongation (≥ 500 msec or an increase of more than 60 msec from baseline);   The number of episodes and number of patients who experience clinically significant extrapyramidal effects (as evidenced by a positive Simpson-Angus Scale Score);   All-cause mortality and 28-day mortality